FDA Identified Problems At Moderna Plant Making Substance For COVID Vaccine: Document
3rd January 2024
U.S. Food and Drug Administration (FDA) inspectors uncovered problems at a Moderna plant used to manufacture a substance that is part of the company’s COVID-19 vaccine, according to a newly released document.
Moderna failed to meet multiple requirements, including rules aimed at minimizing the potential for contamination, according to the document.
FDA inspectors performed inspections at the plant in Norwood, Massachusetts from, Sept. 11 to Sept. 21, visiting nine times in total.